Switching to nebulised short acting bronchodilators does not increase the risk of arrhythmia in patients hospitalized with a COPD exacerbation-Reference-Cited by-同舟云学术

Switching to nebulised short acting bronchodilators does not increase the risk of arrhythmia in patients hospitalized with a COPD exacerbation

Published:2021-11 Issue: Volume:173 Page:105915
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Santus Pierachille^ORCID,Franceschi Elisa^ORCID,Pini Stefano,Frassanito Francesca,Amati Francesco,Danzo Fiammetta,Gatti Marina,Radovanovic Dejan^ORCID

Funder

Boehringer Ingelheim

AstraZeneca

Chiesi Farmaceutici

Publisher

Elsevier BV

Subject

Pharmacology

Reference23 articles.

1. Global Initiative for Chronic Obstructive Lung Disease, Global Strategy for Prevention, Diagnosis and management of COPD, 2021. Available at 〈https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1–25Nov20_WMV.pdf〉.

2. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care;Feary;Thorax,2010

3. Clinical and functional characteristics of COPD patients across GOLD classifications: results of a multicenter observational study;Radovanovic;COPD,2019

4. Cardiac effects of current treatments of chronic obstructive pulmonary disease;Lahousse;Lancet Respir. Med.,2016

5. Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective;Simons;Eur. Heart J.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spirometry in atrial fibrillation: what’s the catch?;Expert Review of Respiratory Medicine;2023-10-03

2. Compound Ipratropium Bromide plus Budesonide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Heparin-Binding Protein;Evidence-Based Complementary and Alternative Medicine;2022-07-04